A Prospective, Open, Uncontrolled, Observational Study With Innolet in Daily Clinical Situations According to the Product Labelling, Without Any Study Specific Investigations.
Phase of Trial: Phase IV
Latest Information Update: 02 Mar 2017
At a glance
- Drugs Insulin (Primary)
- Indications Diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 10 Jun 2017 Biomarkers information updated
- 11 Apr 2012 Actual number of patients changed from 1034 to 1030 as reported by ClinicalTrials.gov.
- 19 Dec 2011 New trial record